Ticker >

Nephro Care India share price

Nephro Care India Ltd.

NSE: NEPHROCARE SECTOR: Hospital & Healthcare Services  1173   0   0

312.45
+28.40 (10.00%)
NSE: 26 Jul 03:44 PM

Price Summary

Today's High

₹ 312.45

Today's Low

₹ 298

52 Week High

₹ 312.45

52 Week Low

₹ 171

FinStar

Ownership Below Par
Stock price may face volatility due to ownership structure.
ValuationAttractive
The stock is considerably attractive based on intrinsic value.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsWeak
Watch out! The company might not be able to sustain any adverse condition.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

515.12 Cr.

Enterprise Value

515.26 Cr.

No. of Shares

1.65 Cr.

P/E

265.19

P/B

8.17

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  38.27

CASH

2.32 Cr.

DEBT

2.46 Cr.

Promoter Holding

-

EPS (TTM)

₹  1.18

Sales Growth

399.14%

ROE

132.46 %

ROCE

72.09%

Profit Growth

0 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year399.14%
3 YearNA
5 YearNA

Profit Growth

1 Year19920.41%
3 YearNA
5 YearNA

ROE%

1 Year132.46%
3 Year239.98%

ROCE %

1 Year72.09%
3 Year31.37%

Debt/Equity

1.0108

Price to Cash Flow

119.57

Interest Cover Ratio

19.2443

CFO/PAT (5 Yr. Avg.)

0

Share Holding Pattern

Investors List Share Holding Data is not available for this company.Report us
* Figures given above are % of equity capital

 Strengths

  • Company has been maintaining healthy ROE of 239.984033333333% over the past 3 years.
  • Company has been maintaining healthy ROCE of 31.3650666666667% over the past 3 years.
  • Company has a healthy Interest coverage ratio of 19.2443.
  • The company has an efficient Cash Conversion Cycle of -39.848 days.

 Limitations

  • The company has shown a poor profit growth of 0% for the Past 3 years.
  • The company has shown a poor revenue growth of 0% for the Past 3 years.
  • The company has a low EBITDA margin of 0% over the past 5 years.
  • The company is trading at a high EV/EBITDA of 141.2575.

Quarterly Result (All Figures in Cr.)

Quarterly Data is not available for this company.Report us

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023
Net Sales 1.82 3.42 17.09
Total Expenditure 1.67 3.3 13.45
Operating Profit 0.15 0.13 3.65
Other Income 0.01 0 0
Interest 0.03 0.02 0.15
Depreciation 0.01 0.11 0.79
Exceptional Items 0 0 0
Profit Before Tax 0.12 0 2.71
Tax 0.03 0.01 0.77
Net Profit 0.09 -0.01 1.94
Adjusted EPS (Rs.) 4.44 -0.01 1.94

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023
Equity and Liabilities
Share Capital 0.01 0.5 0.5
Total Reserves 0.01 0 1.94
Borrowings 0.63 2.46 2.42
Other N/C liabilities 0.01 0.02 -0.06
Current liabilities 0.48 1.65 3.42
Total Liabilities 1.13 4.63 8.22
Assets
Net Block 0.06 1.39 3.05
Capital WIP 0.45 1.9 0
Intangible WIP 0 0 0
Investments 0 0 2
Loans & Advances 0 0.23 0.23
Other N/C Assets 0.1 0.02 0
Current Assets 0.52 1.08 2.94
Total Assets 1.13 4.63 8.22
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023
Profit from operations 0.12 0 2.71
Adjustment 0.03 0.13 0.82
Changes in Assets & Liabilities 0.05 0.56 0.73
Tax Paid 0.03 -0.07 0.04
Operating Cash Flow 0.23 0.62 4.31
Investing Cash Flow -0.06 -2.81 -2.52
Financing Cash Flow 0.28 2.32 -0.08
Net Cash Flow 0.44 0.13 1.71

Corporate Actions

Investors Details

 No Promoters Data available for this company.
Report us
 No Investors Data available for this company.
Report us

Annual Reports

No Annual reports exist for this company.Report us

Ratings & Research Reports

No Credit and Research reports exist for this company.Report us

Company Presentations

Currently we do not have any Presentation and Concall related to this company.Report us

Nephro Care India Stock Price Analysis and Quick Research Report. Is Nephro Care India an attractive stock to invest in?

 

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Nephro Care India and its performance over the period of time. Nephro Care India stock price today is Rs 312.45.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Nephro Care India cash from the operating activity was Rs 4.3081 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Nephro Care India has a Debt to Equity ratio of 1.0108 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Nephro Care India , the EPS growth was 0 % which is bad for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Nephro Care India has OPM of 21.3266482182452 % which is a good sign for profitability.
     
  • ROE: Nephro Care India have a healthy ROE of 132.4604 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Nephro Care India is Rs 312.45. One can use valuation calculators of ticker to know if Nephro Care India share price is undervalued or overvalued.
Last Updated on:
Brief about Nephro Care India
X